Sharp John P
Insider CIK 1342894 · PHAS Chief Financial Officer · LGNDD VP Finance and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAS PhaseBio Pharmaceuticals I | A Award | 2022-05-20 | 2022-05-24 | 6,026 | $0.68 | $4.1K | 65,767 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 24,750 | — | $0 | 24,750 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-02-24 | 2022-02-28 | 115,500 | — | $0 | 115,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-11-19 | 2021-11-23 | 2,017 | $2.01 | $4.1K | 59,741 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2021-11-03 | 2021-11-03 | 7,500 | $1.68 | $12.6K | 90,582 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2021-11-03 | 2021-11-03 | 7,500 | $1.68 | $12.6K | 57,724 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2021-08-03 | 2021-09-03 | 7,500 | — | $0 | 98,082 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-08-03 | 2021-08-04 | 7,500 | $1.68 | $12.6K | 50,224 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2021-08-03 | 2021-09-03 | 7,500 | $1.68 | $12.6K | 50,224 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2021-05-20 | 2021-05-24 | 1,419 | $2.80 | $4.0K | 42,724 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-02-05 | 2021-02-09 | 76,500 | — | $0 | 76,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award | 2020-11-20 | 2020-11-23 | 1,305 | $3.00 | $3.9K | 41,305 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2020-08-14 | 2020-08-17 | 5,000 | — | $0 | 105,582 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2020-08-14 | 2020-08-17 | 5,000 | $1.69 | $8.4K | 40,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-02-12 | 2020-02-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2019-08-21 | 2019-08-22 | 5,000 | — | $0 | 4,038 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2019-08-21 | 2019-08-22 | 10,000 | — | $0 | 110,582 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2019-08-21 | 2019-08-22 | 5,000 | $1.44 | $7.2K | 35,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2019-08-21 | 2019-08-22 | 10,000 | $1.69 | $16.9K | 30,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2019-05-22 | 2019-05-24 | 15,000 | — | $0 | 120,582 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2019-05-22 | 2019-05-24 | 15,000 | $1.69 | $25.4K | 20,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-12-07 | 2018-12-11 | 5,000 | $3.84 | $19.2K | 5,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 16,666 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 2,879 | — | $0 | 8,917 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 10,789 | — | $0 | 13,125 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 4,584 | — | $0 | 10,984 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,166 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 1,000 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 14,622 | — | $0 | 8,582 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 6,086 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 7,495 | — | $0 | 347 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 8,333 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 6,012 | — | $0 | 0 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2014-02-12 | 2014-02-14 | 7,321 | — | $0 | 6,012 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 7,321 | $21.00 | $153.7K | 24,988 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 8,333 | $75.73 | $631.1K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 8,333 | $40.86 | $340.5K | 26,000 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 1,000 | $74.27 | $74.3K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 1,000 | $16.14 | $16.1K | 18,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 16,666 | $74.27 | $1.24M | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 16,666 | $16.14 | $269.0K | 34,333 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 1,166 | $74.27 | $86.6K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 1,166 | $21.00 | $24.5K | 18,833 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 7,495 | $74.27 | $556.7K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 7,495 | $9.96 | $74.7K | 25,162 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 4,584 | $74.27 | $340.5K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 4,584 | $21.92 | $100.5K | 22,251 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 14,622 | $74.27 | $1.09M | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 14,622 | $14.47 | $211.6K | 32,289 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 2,879 | $75.73 | $218.0K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 2,879 | $14.47 | $41.7K | 20,546 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 10,789 | $75.73 | $817.1K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 10,789 | $10.05 | $108.4K | 28,456 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 6,086 | $74.27 | $452.0K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 6,086 | $10.05 | $61.2K | 23,753 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 6,012 | $75.73 | $455.3K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2014-02-12 | 2014-02-14 | 6,012 | $21.00 | $126.3K | 23,679 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2014-02-12 | 2014-02-14 | 7,321 | $74.27 | $543.7K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-12-12 | 2013-12-16 | 700 | — | $0 | 7,842 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-12-12 | 2013-12-16 | 700 | $9.96 | $7.0K | 18,367 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-12-12 | 2013-12-16 | 700 | $53.44 | $37.4K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-12-06 | 2013-12-09 | 6,000 | $56.08 | $336.5K | 17,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-11-18 | 2013-11-20 | 624 | — | $0 | 8,542 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-11-18 | 2013-11-20 | 624 | $9.96 | $6.2K | 24,790 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-11-18 | 2013-11-20 | 1,123 | $53.00 | $59.5K | 23,667 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise deriv | 2013-08-16 | 2013-08-20 | 7,500 | — | $0 | 9,166 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | S Sale | 2013-08-16 | 2013-08-20 | 7,500 | $42.75 | $320.6K | 24,166 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | M Exercise | 2013-08-16 | 2013-08-20 | 7,500 | $9.96 | $74.7K | 31,666 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-19 | 15,568 | $21.92 | $341.3K | 15,568 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award deriv | 2013-02-15 | 2013-02-19 | 4,432 | $21.92 | $97.1K | 4,432 | SEC↗ |
| LGND LIGAND PHARMACEUTICALS INC | A Award | 2013-02-15 | 2013-02-19 | 2,500 | — | $0 | 24,166 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 11,796 | $14.47 | $170.7K | 11,796 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | A Award deriv | 2012-02-09 | 2012-02-13 | 23,204 | $14.47 | $335.8K | 23,204 | SEC↗ |
| LGNDD LIGAND PHARMACEUTICALS INC | A Award | 2012-02-09 | 2012-02-13 | 5,000 | — | $0 | 21,666 | SEC↗ |